SGLT2 Inhibitors and GLP-1 Drugs Show Greater Kidney Benefits in Diabetes Patients With Albuminuria: BMJ

Coverage, in order

1. 5d ago
   
   Medical Dialogues India obscure peer-reviewedn=75,000

   SGLT2 Inhibitors and GLP-1 Drugs Show Greater Kidney Benefits in Diabetes Patients With Albuminuria: BMJ

   USA: A study involving more than 75,000 people with type 2 diabetes found lower rates of kidney deterioration with SGLT2 inhibitors or GLP-1 receptor agonists among patients with albuminuria , but not among those without it. Two patients with type 2 diabetes may have similar HbA1c levels and kidney…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.